504 related articles for article (PubMed ID: 9814969)
1. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
[TBL] [Abstract][Full Text] [Related]
2. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
Tang H; Zhao ZJ; Landon EJ; Inagami T
J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.
Amiri F; Shaw S; Wang X; Tang J; Waller JL; Eaton DC; Marrero MB
Kidney Int; 2002 May; 61(5):1605-16. PubMed ID: 11967010
[TBL] [Abstract][Full Text] [Related]
6. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
7. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.
Doan T; Farmer P; Cooney T; Ali MS
Cell Signal; 2004 Mar; 16(3):301-11. PubMed ID: 14687660
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.
Shaw S; Bencherif M; Marrero MB
J Neurosci; 2003 Dec; 23(35):11224-8. PubMed ID: 14657181
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1.
Venema RC; Venema VJ; Eaton DC; Marrero MB
J Biol Chem; 1998 Nov; 273(46):30795-800. PubMed ID: 9804857
[TBL] [Abstract][Full Text] [Related]
10. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
Jiao H; Berrada K; Yang W; Tabrizi M; Platanias LC; Yi T
Mol Cell Biol; 1996 Dec; 16(12):6985-92. PubMed ID: 8943354
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
Shibasaki Y; Matsubara H; Nozawa Y; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
Hypertension; 2001 Sep; 38(3):367-72. PubMed ID: 11566906
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
McWhinney CD; Dostal D; Baker K
J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
[TBL] [Abstract][Full Text] [Related]
13. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
Kim HY; Park EJ; Joe EH; Jou I
J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
[TBL] [Abstract][Full Text] [Related]
14. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
Seta K; Sadoshima J
J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
[TBL] [Abstract][Full Text] [Related]
16. Raft-mediated Src homology 2 domain-containing proteintyrosine phosphatase 2 (SHP-2) regulation in microglia.
Kim HY; Park SJ; Joe EH; Jou I
J Biol Chem; 2006 Apr; 281(17):11872-8. PubMed ID: 16507579
[TBL] [Abstract][Full Text] [Related]
17. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
Ram PA; Waxman DJ
J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
19. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
Li C; Friedman JM
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.
Marrero MB; Papke RL; Bhatti BS; Shaw S; Bencherif M
J Pharmacol Exp Ther; 2004 Apr; 309(1):16-27. PubMed ID: 14722323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
